LEONARD S. JACOB - 27 Aug 2021 Form 4 Insider Report for ANTARES PHARMA, INC.

Role: Director
Signature: /s/ Lisa M. Kallebo as attorney-in-fact for Leonard S. Jacob
Issuer symbol: N/A
Transactions as of: 27 Aug 2021
Net transactions value: +$0.96
Form type: 4
Filing time: 31 Aug 2021, 18:26:04 UTC
Previous filing: 14 Jun 2021
Next filing: 04 Feb 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	ATRS	Common Stock	Award	$55,281	+24,679	+8.7%	$2.24	309,395	27 Aug 2021	Direct
transaction	ATRS	Common Stock	Tax liability	$55,280	-13,820	-4.5%	$4.00	295,575	27 Aug 2021	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	ATRS	Stock Option (right to buy)	Options Exercise	$0	+24,679		$0.000000^*	0	27 Aug 2021	Common Stock	24,679	$2.24	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents the number of shares withheld by the company to cover the exercise price for the underlying stock option exercise. No shares were actually sold.
F2	The options vested and became exercisable one year from the grant date of September 9, 2011. The stock options were due to expire on September 8, 2021.